NVO FY 2015 Earnings Report — Novo Nordisk A/S Revenue & Financial Results | Market Cap Arena

Novo Nordisk A/SNVO

FY 2015 Earnings

Reported December 30, 2015

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2015	Prior Q	FY 2014	QoQ Change	YoY Change
Revenue	$16.9B	—	$13.9B	—	21.5%
Op. Income	$7.7B	—	$5.4B	—	43.3%
Gross Margin	85.0%	—	83.6%	—	1.4pp
Net Margin	32.3%	—	29.8%	—	2.5pp
EPS (Diluted)	$1.06	—	$0.79	—	34.1%
Free Cash Flow	$5.0B	—	$4.3B	—	16.5%

Revenue Flow

Item	Amount
REVENUE	$16.9B
Cost of Revenue	$2.5B
GROSS PROFIT	$14.4B
R&D Expenses	$2.1B
Selling & Marketing	$4.4B
General & Administrative	$604M
SG&A Expenses	$5.0B
Other Expenses	-$546M
Operating Expenses	$6.6B
Cost & Expenses	$9.2B
OPERATING INCOME	$7.7B
Interest Income	$9M
Interest Expense	$10M
Other Income/Expenses	-$934M
INCOME BEFORE TAX	$6.8B
Income Tax Expense	$1.4B
Net Income from Continuing Ops	$5.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.5B
D&A	$464M
EBIT	$6.8B
EBITDA	$7.3B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$16.9B
Cost of Revenue	$2.5B
GROSS PROFIT	$14.4B
R&D Expenses	$2.1B
Selling & Marketing	$4.4B
General & Administrative	$604M
SG&A Expenses	$5.0B
Other Expenses	-$546M
Operating Expenses	$6.6B
Cost & Expenses	$9.2B
OPERATING INCOME	$7.7B
Interest Income	$9M
Interest Expense	$10M
Other Income/Expenses	-$934M
INCOME BEFORE TAX	$6.8B
Income Tax Expense	$1.4B
Net Income from Continuing Ops	$5.5B
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$5.5B
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$5.5B
D&A	$464M
EBIT	$6.8B
EBITDA	$7.3B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$5.5B
Depreciation & Amortization	$464M
Stock-Based Compensation	$69M
Deferred Income Tax	$1.4B
Other Non-Cash Items	-$1.0B
Change in Working Capital	-$338M
OPERATING CASH FLOW	$6.0B
Capital Expenditure	-$1.0B
Acquisitions (Net)	$361M
Purchases of Investments	-$555M
Sales/Maturities of Investments	$240M
Other Investing Activities	$2M
NET CASH FROM INVESTING	-$955M
Net Debt Issuance	$0
Common Stock Repurchased	-$2.7B
Common Dividends Paid	-$2.0B
Other Financing Activities	$0
NET CASH FROM FINANCING	-$4.7B
FREE CASH FLOW	$5.0B
Net Change in Cash	$341M

Balance Sheet

Item	Amount
Cash & Equivalents	$2.7B
Short-Term Investments	$555M
Net Receivables	$2.8B
Inventory	$2.0B
Other Current Assets	$1.0B
TOTAL CURRENT ASSETS	$8.6B
PP&E (Net)	$4.0B
Goodwill	$0
Intangible Assets	$338M
Long-Term Investments	$337M
Tax Assets	$1.1B
Other Non-Current Assets	$0
TOTAL NON-CURRENT ASSETS	$5.7B
TOTAL ASSETS	$14.4B
Account Payables	$772M
Short-Term Debt	$168M
Deferred Revenue	$3.3B
Other Current Liabilities	$4.2B
TOTAL CURRENT LIABILITIES	$6.4B
Long-Term Debt	$0
Deferred Revenue NC	$0
Deferred Tax Liabilities	$940.0K
Other Non-Current Liabilities	$619M
TOTAL NON-CURRENT LIABILITIES	$620M
TOTAL LIABILITIES	$7.0B
Common Stock	$81M
Additional Paid-In Capital	$81M
Retained Earnings	$7.3B
Treasury Stock	-$2M
Accum. Other Comp. Income	-$56M
Other Equity	-$81M
TOTAL STOCKHOLDERS' EQUITY	$7.4B
Minority Interest	$0
TOTAL EQUITY	$7.4B
TOTAL LIABILITIES & EQUITY	$14.4B
Total Debt	$168M
Net Debt	-$2.5B